TABLE 2.
Health-related quality of life and satisfaction with prostate cancer care
Variable | Value |
---|---|
Baseline quality of life pretreatment, mean (SD) | |
SF-36 MCS | 52.5 (8.96) |
SF-36 PCS | 51.3 (8.96) |
Fear of cancer recurrence | 36 (17.79) |
Decline in quality of life at 1–2 years after treatment, n (%) | |
PCI sexual function | 1086 (55) |
PCI bowel function | 484 (24) |
PCI urinary function | 918 (46) |
Satisfaction with care pretreatment, mean (SD) | |
Overall satisfaction with care | 77.5 (16.19) |
Amount of contact | 74.7 (21.16) |
Communication | 78.5 (18.07) |
Humanness | 81.8 (17.83) |
Competence | 82.9 (18.77) |
Satisfaction with care at 1–2 years after treatment, mean (SD) | |
Overall satisfaction with care | 78.2 (15.36) |
Amount of contact | 77.7 (18.97) |
Communication | 76.6 (19.18) |
Humanness | 82.5 (16.65) |
Competence | 82.4 (17.55) |
Defined as decline > 1 SD from baseline.
MCS, Mental Component Summary; PCI, Prostate Cancer Index; PCS, Physical Component Summary; SF-36, 36-item short-form health survey.